Personalis
Stephane Mouradian has a vast amount of experience in the life science industry, holding various positions in business development, venture investing, and advisory roles. Currently serving as the Senior Vice President of Business Development & Marketing at Personalis, Inc., Stephane also advises on life science investments as an Advisory Board Member at Arboretum Ventures. With a Ph.D. in Analytical chemistry and DNA Sequencing from the University of Wisconsin - Madison, Stephane has a strong background in scientific research and has held positions at notable companies such as Illumina, PerkinElmer, and Caliper Life Sciences. Stephane's expertise lies in venture investment, M&A, and business development for clinical genomics, particularly in prenatal and oncology diagnostics.
Personalis
4 followers
Personalis is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA Million Veteran Program (MVP). In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis® ImmunoID NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP-aligned as well as CLIA’88-certified and CAP-accredited.